Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 550 of 2026 entries
View as:

A Study to Evaluate the Effect of Aleglitazar on Cardiac Energetics and Function in Patients With Type 2 Diabetes Mellitus and no History of Coronary Artery Disease

Phase: N/A Priority: Normal
NCT ID: NCT01680978 Org: User:
Start: 10/31/12 End: 09/30/13 Due: 09/30/14

A Study of Erlotinib [Tarceva] as Monotherapy or Intermittent Dosing With Docetaxel in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer. (TALISMAN)

Phase: N/A Priority: Normal
NCT ID: NCT01204697 Org: User:
Start: 11/30/10 End: 07/31/14 Due: 07/31/15

A Study of the Effect of Multiple Doses of Rifampin on the Single Dose Pharmacokinetics of RO5424802

Phase: N/A Priority: Normal
NCT ID: NCT01940510 Org: User:
Start: 10/31/13 End: 10/31/13 Due: 10/31/14

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Idasanutlin Monotherapy in Participants With Hydroxyurea-Resistant/Intolerant Polycythemia Vera

Phase: N/A Priority: Normal
NCT ID: NCT03287245 Org: User:
Start: 02/21/18 End: 03/03/20 Due: 03/03/21

A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone Disease

Phase: N/A Priority: Normal
NCT ID: NCT00099203 Org: User:
Start: 07/31/05 End: 12/31/07 Due: 12/31/08

A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis

Phase: N/A Priority: Normal
NCT ID: NCT02598934 Org: User:
Start: 08/31/04 End: 05/31/06 Due: 05/31/07

A Study of the Safety of Atezolizumab in Participants With Locally Advanced or Metastatic Non Small Cell Lung Cancer in Argentina

Phase: N/A Priority: Normal
NCT ID: NCT03321695 Org: User:
Start: 12/27/17 End: 03/02/19 Due: 03/02/20

A Study of Combination Therapy With PEGASYS (Pegylated Interferon Alfa-2a (40KD)) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 2 or 3 Who Do Not Achieve a Rapid Viral Response

Phase: N/A Priority: Normal
NCT ID: NCT00623428 Org: User:
Start: 06/30/08 End: 05/31/12 Due: 05/31/13

A Study to Evaluate the Use of Glucocorticoids in Combination With Tocilizumab in Daily Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT03291457 Org: User:
Start: 03/30/17 End: 12/04/19 Due: 12/04/20

A Study of Avastin (Bevacizumab) Combined With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum

Phase: N/A Priority: Normal
NCT ID: NCT01181609 Org: User:
Start: 06/30/05 End: 05/31/10 Due: 05/31/11

A Study of Mircera for the Treatment of Anemia in Dialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT00077597 Org: User:
Start: 02/29/04 End: 06/30/06 Due: 06/30/07

A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs (REMISSION)

Phase: N/A Priority: Normal
NCT ID: NCT01610791 Org: User:
Start: 03/31/10 End: 08/31/11 Due: 08/31/12

A Study of the Pharmacokinetics And Pharmacodynamics of Intravenously Administered Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C And Previous Non-Response to Pegylated Interferon And Ribavirin Combination Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01337375 Org: User:
Start: 03/31/11 End: 04/30/12 Due: 04/30/13

A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00089492 Org: User:
Start: 07/31/04 End: 06/30/06 Due: 06/30/07

A Study of Verutex (Fusidic Acid), Eritex (Erythromycin) and Fisiogel in the Management of Tarceva-Associated Rash.

Phase: N/A Priority: Normal
NCT ID: NCT00718315 Org: User:
Start: 04/30/09 End: 06/30/12 Due: 06/30/13

A Study of Bevacizumab (Avastin) in Combination With Dacarbazine in Participants With Unresectable/Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01164007 Org: User:
Start: 06/30/06 End: 05/31/12 Due: 05/31/13

A Study to Detect V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) V600 Mutation on Cell-Free Deoxyribonucleic Acid (cfDNA) From Plasma in Participants With Advanced Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT02768207 Org: User:
Start: 05/23/16 End: 06/27/19 Due: 06/27/20

An Observational Follow-up Study of 1st-Line Treatment With Herceptin (Trastuzumab) in Patients With Metastatic Breast Cancer (Post-HERMINE)

Phase: N/A Priority: Normal
NCT ID: NCT01332981 Org: User:
Start: 02/28/10 End: 10/31/10 Due: 10/31/11

A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03498716 Org: User:
Start: 08/02/18 End: 08/14/23 Due: 08/14/24

A Long-term Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00721123 Org: User:
Start: 08/31/05 End: 05/31/12 Due: 05/31/13

Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study

Phase: N/A Priority: Normal
NCT ID: NCT04589845 Org: User:
Start: 01/18/21 End: 09/25/32 Due: 09/25/33

A Study on Emergence of Resistance With Oseltamivir (Tamiflu) in Participants With Seasonal Influenza

Phase: N/A Priority: Normal
NCT ID: NCT00949533 Org: User:
Start: 08/31/09 End: 10/31/10 Due: 10/31/11

MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis

Phase: N/A Priority: Normal
NCT ID: NCT00048061 Org: User:
Start: 04/30/02 End: 12/31/04 Due: 12/31/05

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Anastrozole Plus Palbociclib for Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Untreated Early Breast Cancer (coopERA Breast Cancer)

Phase: N/A Priority: Normal
NCT ID: NCT04436744 Org: User:
Start: 09/04/20 End: 11/24/21 Due: 11/24/22

A Study To Assess Distribution Of RO7248824 In The Central Nervous System Following Single Intrathecal Doses Of [89zr] Labeled RO7248824 In Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT04863794 Org: User:
Start: 04/29/21 End: 08/01/22 Due: 08/01/23